Clínica Baviera, S.A. Stock price

Equities

CBAV

ES0119037010

Healthcare Facilities & Services

Delayed BME 12:35:12 2024-03-28 pm EDT 5-day change 1st Jan Change
28.3 EUR -0.70% Intraday chart for Clínica Baviera, S.A. 0.00% +23.04%
Sales 2020 123M 132M Sales 2021 173M 187M Capitalization 346M 372M
Net income 2020 13M 14.01M Net income 2021 27M 29.1M EV / Sales 2020 2.1 x
Net Debt 2020 27.76M 29.91M Net Debt 2021 19.13M 20.62M EV / Sales 2021 2.11 x
P/E ratio 2020
16.5 x
P/E ratio 2021
12.6 x
Employees 1,466
Yield 2020
3.91%
Yield 2021
4.86%
Free-Float 8.31%
More Fundamentals * Assessed data
Dynamic Chart
Clínica Baviera, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Clínica Baviera, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Clínica Baviera, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Clínica Baviera, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Clínica Baviera, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
IBEX Gender Equality Index Adds 17 Companies MT
Clínica Baviera, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Clínica Baviera, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Clínica Baviera, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Clínica Baviera, S.A. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Clínica Baviera, S.A. acquired Loiola Visión from Manuel Salaberría. CI
Aier Eye International, S.L.U. completed the acquisition of 86.8% stake in Clínica Baviera, S.A. from Corporación Financiera Alba, S.A., Grupo Empresarial Zriser SA, Netsa Investments, B.V., Eduardo Baviera Sabater, Fernando Llovet Osuna, Julio Baviera Sabater and others for approximately €150 million. CI
Clínica Baviera, S.A. Reports Unaudited Consolidated Earnings Results for the Second Quarter and First Half of 2017 CI
Clínica Baviera, S.A. Announces Consolidated Earnings Results for the First Quarter of 2017 CI
Aier Eye International, S.L.U. made an offer to acquire Clínica Baviera, S.A. from Corporación Financiera Alba, S.A., Grupo Empresarial Zriser SA, Netsa Investments, B.V., Eduardo Baviera Sabater, Fernando Llovet Osuna, Julio Baviera Sabater and others for approximately €150 million. CI
More news
1 day-0.70%
Current month+5.60%
1 month+9.69%
3 months+23.04%
6 months+40.80%
Current year+23.04%
More quotes
1 week
27.60
Extreme 27.6
28.90
1 month
26.30
Extreme 26.3
29.30
Current year
22.70
Extreme 22.7
29.30
1 year
17.30
Extreme 17.3
29.30
3 years
12.60
Extreme 12.6
29.30
5 years
8.00
Extreme 8
29.30
10 years
4.40
Extreme 4.4
29.30
More quotes
Managers TitleAgeSince
Founder 57 92-02-04
Members of the board TitleAgeSince
Director/Board Member 62 20-10-20
Founder 57 92-02-04
Chairman 59 17-08-30
More insiders
Date Price Change Volume
24-03-28 28.3 -0.70% 7,469
24-03-27 28.5 +2.89% 1,815
24-03-26 27.7 -2.46% 3,636
24-03-25 28.4 +0.35% 1,009
24-03-22 28.3 0.00% 1,263

Delayed Quote BME, March 28, 2024 at 12:35 pm EDT

More quotes
Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The Company operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Clínica Baviera, S.A. - BME